Today’s top gainers include the company Eli Lilly and Company (NYSE:LLY) which is in the industry Drug Manufacturers – Major, gaining -0.24% today. In the last week its performance is 1.16%, and 4.85% for the past quarter. Currently, Eli Lilly and Company, LLY has a target price of 95.67, so today’s gain of -0.24% is a significant step towards its target price. The GAP today is therefore -0.10%.
Eli Lilly and Company (NYSE:LLY), has a market cap of 89077.88, and is based in USA. Insider ownership is at 11.60%, and institutional ownership is 76.40%.
At the current price of 80.09, it has a dividend yield of 2.54%, and its target price is 95.67. This is with a profit margin of 11.50%, and total debt/equity of 0.54. Eli Lilly and Company (NYSE:LLY) has a P/E of 36.84, as well as a forward P/E of 20.11.
With a current EPS of 2.18, and a forecasted EPS growth for next year at 11.97%,Eli Lilly and Company (NYSE:LLY) has had a EPS growth for the past five years at -13.20%. For the next five years EPS growth is projected to be 12.87%.
Performance for the year is -3.72%. Since its IPO date on 6/1/1972, the total performance to date is -3.42%.
Volume today for Eli Lilly and Company (NYSE:LLY), is 1237281, while its average volume is 4170.67. Whilst the total gain today was -0.24%, it did have a day high of -1.13%.
Volatility for this week has been at 1.07%, and 1.70% for the month. The 52-week low for Eli Lilly and Company, LLY has been 18.77%, while the 52-week-high has reached -12.01%.
Looking at its return of investments, which is 9.50%, and its return on assets is 6.50%. Eli Lilly and Company (NYSE:LLY) has an operating margin of 13.40%. With a sales growth of 4.70% quarter over quarter. Bearing in mind that Eli Lilly and Company, LLY is in the sector Healthcare, its long-term debt/equity is 0.5, and has a current ratio of 1.6 and 1.1 for quick ratio.
So what is the value of Eli Lilly and Company? Well its PEG is 2.86, and the P/S is 4.41, along with a P/B of 5.67. Meanwhile it has a p/cash of 29.74.